Welcome
Welcome to the EPSRC-Pharma Synthesis Network website.
The Network is a unique collaboration bringing together the relevant government sponsored scientific funding agency, the EPSRC, and the three largest UK-based Pharmaceutical Research companies, AstraZeneca, Glaxo SmithKline and Pfizer. The main objective is to maintain and strengthen support for synthetic organic chemistry research, which underpins R&D in the pharmaceutical industry.
The focus of the programme is the sponsorship and support of PhD studentships. The studentships are jointly funded by the EPSRC and the collaborating companies and are awarded on the basis of competitive review of proposals submitted by academics from UK universities. Initially the programme is being run as a 2-year pilot. The first 15 studentships started in October 2007 and a further 15 due have been announced and are due to commence in October 2008.
Through this new way of funding research at graduate level we hope to create a model whereby industry and research councils collaborate to fund areas of research that are vital to the UK economy, in a way that provides students with excellent training opportunities and enables UK academia to produce world-class research.